Literature DB >> 18714026

Splenectomy protects against sepsis lethality and reduces serum HMGB1 levels.

Jared M Huston1, Haichao Wang, Mahendar Ochani, Kanta Ochani, Mauricio Rosas-Ballina, Margot Gallowitsch-Puerta, Mala Ashok, Lihong Yang, Kevin J Tracey, Huan Yang.   

Abstract

High mobility group box 1 (HMGB1) is a critical mediator of lethal sepsis. Previously, we showed that apoptotic cells can activate macrophages to release HMGB1. During sepsis, apoptosis occurs primarily in lymphoid organs, including the spleen and thymus. Currently, it is unclear whether this accelerated lymphoid organ apoptosis contributes to systemic release of HMGB1 in sepsis. In this study, we report that splenectomy significantly reduces systemic HMGB1 release and improves survival in mice with polymicrobial sepsis. Treatment with a broad-spectrum caspase inhibitor reduces systemic lymphocyte apoptosis, suppresses circulating HMGB1 concentrations, and improves survival during polymicrobial sepsis, but fails to protect septic mice following splenectomy. These findings indicate that apoptosis in the spleen is essential to the pathogenesis of HMGB1-mediated sepsis lethality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18714026      PMCID: PMC4533852          DOI: 10.4049/jimmunol.181.5.3535

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Splenectomy differentially influences immune responses in various tissue compartments of the body.

Authors:  Kang Shih-Ching; Mashkoor A Choudhry; Takeshi Matsutani; Martin G Schwacha; Loring W Rue; Kirby I Bland; Irshad H Chaudry
Journal:  Cytokine       Date:  2004-11-07       Impact factor: 3.861

2.  Prevention and management of infections in patients without a spleen.

Authors:  R N Davidson; R A Wall
Journal:  Clin Microbiol Infect       Date:  2001-12       Impact factor: 8.067

Review 3.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal.

Authors:  Michael T Lotze; Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2005-04       Impact factor: 53.106

4.  The extracellular release of HMGB1 during apoptotic cell death.

Authors:  Charles W Bell; Weiwen Jiang; Charles F Reich; David S Pisetsky
Journal:  Am J Physiol Cell Physiol       Date:  2006-07-19       Impact factor: 4.249

5.  A study of 42 episodes of overwhelming post-splenectomy infection: is current guidance for asplenic individuals being followed?

Authors:  D J Waghorn; R T Mayon-White
Journal:  J Infect       Date:  1997-11       Impact factor: 6.072

Review 6.  The apoptotic pathway as a therapeutic target in sepsis.

Authors:  Doreen E Wesche-Soldato; Ryan Z Swan; Chun-Shiang Chung; Alfred Ayala
Journal:  Curr Drug Targets       Date:  2007-04       Impact factor: 3.465

Review 7.  Extracellular role of HMGB1 in inflammation and sepsis.

Authors:  H Wang; H Yang; K J Tracey
Journal:  J Intern Med       Date:  2004-03       Impact factor: 8.989

8.  Reversing established sepsis with antagonists of endogenous high-mobility group box 1.

Authors:  Huan Yang; Mahendar Ochani; Jianhua Li; Xiaoling Qiang; Mahira Tanovic; Helena E Harris; Srinivas M Susarla; Luis Ulloa; Hong Wang; Robert DiRaimo; Christopher J Czura; Haichao Wang; Jesse Roth; H Shaw Warren; Mitchell P Fink; Matthew J Fenton; Ulf Andersson; Kevin J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-26       Impact factor: 11.205

9.  HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice.

Authors:  Penny L Sappington; Runkuan Yang; Huan Yang; Kevin J Tracey; Russell L Delude; Mitchell P Fink
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

10.  Role of HMGB1 in apoptosis-mediated sepsis lethality.

Authors:  Shixin Qin; Haichao Wang; Renqi Yuan; Hui Li; Mahendar Ochani; Kanta Ochani; Mauricio Rosas-Ballina; Chris J Czura; Jared M Huston; Ed Miller; Xinchun Lin; Barbara Sherry; Anjali Kumar; Greg Larosa; Walter Newman; Kevin J Tracey; Huan Yang
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  38 in total

1.  Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1.

Authors:  Asada Leelahavanichkul; Yuning Huang; Xuzhen Hu; Hua Zhou; Takayuki Tsuji; Richard Chen; Jeffrey B Kopp; Jürgen Schnermann; Peter S T Yuen; Robert A Star
Journal:  Kidney Int       Date:  2011-08-10       Impact factor: 10.612

2.  Continuous enteral and parenteral feeding each reduces heart rate variability but differentially influences monocyte gene expression in humans.

Authors:  Stephen C Gale; Beth-Ann Shanker; Susette M Coyle; Marie A Macor; Chun W Choi; Steve E Calvano; Siobhan A Corbett; Stephen F Lowry
Journal:  Shock       Date:  2012-08       Impact factor: 3.454

Review 3.  Rethinking inflammation: neural circuits in the regulation of immunity.

Authors:  Peder S Olofsson; Mauricio Rosas-Ballina; Yaakov A Levine; Kevin J Tracey
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

4.  Effect of hypothermia on splenic leukocyte modulation and survival duration in severely septic rats.

Authors:  Rhett N Willis; Eric J Charles; Christopher A Guidry; Mahendra D Chordia; Stephen W Davies; Zequan Yang; Robert G Sawyer
Journal:  J Surg Res       Date:  2017-04-07       Impact factor: 2.192

5.  PD-L1 blockade improves immune dysfunction of spleen dendritic cells and T-cells in zymosan-induced multiple organs dysfunction syndromes.

Authors:  Qian Liu; Yi Lv; Min Zhao; Yiduo Jin; Jiangyang Lu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 6.  The intestinal cholinergic anti-inflammatory pathway.

Authors:  Gera Goverse; Michelle Stakenborg; Gianluca Matteoli
Journal:  J Physiol       Date:  2016-05-05       Impact factor: 5.182

7.  Interruption of macrophage-derived IL-27(p28) production by IL-10 during sepsis requires STAT3 but not SOCS3.

Authors:  Markus Bosmann; Norman F Russkamp; Birgit Strobl; Julian Roewe; Liza Balouzian; Florence Pache; Markus P Radsak; Nico van Rooijen; Firas S Zetoune; J Vidya Sarma; Gabriel Núñez; Mathias Müller; Peter J Murray; Peter A Ward
Journal:  J Immunol       Date:  2014-10-27       Impact factor: 5.422

Review 8.  Enteric neuroplasticity and dysmotility in inflammatory disease: key players and possible therapeutic targets.

Authors:  Estelle T Spear; Gary M Mawe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-10-11       Impact factor: 4.052

9.  Accelerated apoptosis contributes to aging-related hyperinflammation in endotoxemia.

Authors:  Mian Zhou; Rongqian Wu; Weifeng Dong; Jennifer Leong; Ping Wang
Journal:  Int J Mol Med       Date:  2010-06       Impact factor: 4.101

10.  Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis.

Authors:  Pengfei Li; Grant Bledsoe; Zhi-Rong Yang; Hongkuan Fan; Lee Chao; Julie Chao
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.